Benzylthiouracil
Benzylthiouracil is a thionamide compound used in research to model hyperthyroidism and its complications. It has been associated with inducing ANCA-associated vasculitis and glomerulonephritis in clinical settings, making it a tool for studying autoimmune mechanisms in endocrine disease models, both in vitro and in vivo.
Product Specifications
CAS Number
6336-50-1
Product Name Alternative
6-Benzyl-2-thiouracil
Field of Research
Pharmacology & Drug Discovery
Purity
99.65% (May vary between batches)
Solubility
DMSO:180 mg/mL (824.63 mM)
Smiles
O=C1C=C (NC (=S) N1) CC=2C=CC=CC2
Molecular Formula
C11H10N2OS
Molecular Weight
218.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1343175-01 0.02 mg (E-Coli)
Recombinant Wigglesworthia glossinidia brevipalpis Crossover junction endodeoxyribonuclease RuvC (ruvC)
Sign In for Pricing
View Details MBS1343175-02 0.1 mg (E-Coli)
Recombinant Wigglesworthia glossinidia brevipalpis Crossover junction endodeoxyribonuclease RuvC (ruvC)
Sign In for Pricing
View Details MBS1343175-03 0.02 mg (Yeast)
Recombinant Wigglesworthia glossinidia brevipalpis Crossover junction endodeoxyribonuclease RuvC (ruvC)
Sign In for Pricing
View Details MBS1343175-04 0.1 mg (Yeast)
Recombinant Wigglesworthia glossinidia brevipalpis Crossover junction endodeoxyribonuclease RuvC (ruvC)
Sign In for Pricing
View Details MBS1343175-05 0.02 mg (Baculovirus)
Recombinant Wigglesworthia glossinidia brevipalpis Crossover junction endodeoxyribonuclease RuvC (ruvC)
Sign In for Pricing
View Details MBS1343175-06 0.02 mg (Mammalian-Cell)
Recombinant Wigglesworthia glossinidia brevipalpis Crossover junction endodeoxyribonuclease RuvC (ruvC)
Sign In for Pricing
View Details